Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

被引：0
|
作者：
Kataeva, Elena
Golenkov, Anatoly
Triphonova, Elena
Dudina, Galina
Mitina, Tatyana
Lutskaya, Tatyana
Vysotskaya, Ludmila
Chernykh, Yulliya
Zakharov, Sergey
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5312.5312
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5312
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Duvelisib (Copiktra) in relapsed or refractory chronic lymphocytic leukemia: safety and efficacy
    Nikolaenko, Liana
    Liu, Tingting
    Danilov, Alexey V.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (05) : 481 - 487
  • [42] Lenalidomide and Rituximab For The Treatment Of Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results Of Planned Interim Analysis
    Choi, Michael Y.
    Castro, Januario E.
    Hoff, Sheila
    Li, Hongying
    Rassenti, Laura
    James, Danelle F.
    Messer, Karen
    Kipps, Thomas J.
    BLOOD, 2013, 122 (21)
  • [43] Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia
    Tedeschi, Alessandra
    Rossi, Davide
    Coscia, Marta
    Vismara, Eleonora
    Petrizzi, Valeria Belsito
    Orlandi, Ester
    Cascavilla, Nicola
    Scarfo, Lydia
    Motta, Marina
    Vitale, Candida
    Ricci, Francesca
    De Paoli, Lorenzo
    D'Arco, Alfonso Maria
    Gallamini, Andrea
    Gaidano, Gianluca
    Morra, Enrica
    Massaia, Massimo
    Montillo, Marco
    BLOOD, 2012, 120 (21)
  • [44] Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia
    R. Kath
    K. Blumenstengel
    H. J. Fricke
    K. Höffken
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 48 - 54
  • [45] Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia
    Kath, R
    Blumenstengel, K
    Fricke, HJ
    Höffken, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) : 48 - 54
  • [46] Lenalidomide active in patients with refractory or relapsed chronic lymphocytic leukemia
    Nature Clinical Practice Oncology, 2007, 4 (3): : 143 - 143
  • [47] Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
    Niemann, Carsten U.
    Levin, Mark-David
    Dubois, Julie
    Kersting, Sabina
    Enggaard, Lisbeth
    Veldhuis, Gerrit J.
    Mous, Rogier
    Mellink, Clemens H. M.
    Dobber, Johan A.
    Poulsen, Christian B.
    Frederiksen, Henrik
    Janssens, Ann
    Schjodt, Ida
    Dompeling, Ellen C.
    Ranti, Juha
    Mattsson, Mattias
    Bellido, Mar
    Tran, Hoa T. T.
    Nasserinejad, Kazem
    Kater, Arnon P.
    BLOOD, 2021, 137 (08) : 1117 - 1120
  • [48] Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Garcia-Marco, Jose
    Tello, Patricia Baltasar
    Garcia, Esther Gonzalez
    Herranz, Eduardo Rios
    Payer, Angel Ramirez
    Castera, Maria Jose Terol
    Champ, Diana
    Perez, Angeles Medina
    Gironella, Mercedes
    Fernandez, Alicia Rodriguez
    Prat, Ana Muntanola
    Cabrera, Alexia Suarez
    Chacon, Manuel Jurado
    Zarzoso, Miguel Fernandez
    Rodriguez, Mercedes
    Clavel, Juana
    Sahun, Maria Victoria Dourdil
    Coll, Christelle M. Ferra
    Persona, Ernesto Perez
    Santos, Carmen Milagros Marrero
    Fores, Rafael
    Delgado, Julio
    BLOOD, 2017, 130
  • [49] Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
    Dretzke, J.
    Barton, P.
    Kaambwa, B.
    Connock, M.
    Uthman, O.
    Bayliss, S.
    Meads, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 19 - 26
  • [50] Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
    Handunnetti, Sasanka
    Anderson, Mary Ann
    Roberts, Andrew W.
    Davids, Matthew S.
    Ma, Shuo
    Boyer, Michelle
    Arzt, Jennifer
    Al Masud, Abdullah
    Popovic, Relja
    Jacobson, Amanda
    Kim, Su Y.
    Seymour, John F.
    EJHAEM, 2021, 2 (02): : 266 - 271
12345